Kim has extensive experience leading strategic engagements across the life sciences industry. In that context, she has helped pharma and biotech companies tackle a diverse range of strategic issues across the product lifecycle, with a specific interest in launch preparation and planning. Kim additionally has deep expertise across therapeutic areas, with a more recent emphasis within rare diseases, hematology/oncology, and cardiovascular/metabolic diseases. Kim is energized by forming collaborative partnerships with clients, helping them craft impactful and actionable solutions to their most pressing challenges.
Kim leverages 10+ years of experience in the life sciences, including translational clinical research at Massachusetts General Hospital prior to joining Clearview. She has spent the majority of her career specifically focused on growth strategy in the life sciences industry, supporting executives at the brand, therapeutic area, and corporate level. Kim earned her B.A. in History of Science from Harvard University.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson